Vivek Walimbe

Vivek Walimbe has a solid background in the medical industry, with expertise in research and development. Vivek is currently serving as the Chief Operating Officer at SpectraWAVE, Inc., where they oversee the operations of the company. Prior to this role, they held the position of Vice President of Research and Development at the same company, leading a talented team in developing an innovative imaging platform for coronary artery disease treatment.

Before joining SpectraWAVE, Vivek worked at Baxter International Inc. for five years, starting as the Director of Engineering and advancing to the role of Vice President of Research and Development. Vivek also served as the Senior Director of Engineering during their time at Baxter.

Vivek's experience in the medical sector began at Medtronic, where they worked as a Senior Manager of New Product Development. Vivek then moved on to GE Healthcare, initially taking a role as a Staff Engineer in X-ray Imaging and Advanced Applications. Vivek later became the Functional Team Lead and eventually the Engineering Manager for the Rad/R&F Imaging and Advanced Applications division at GE Healthcare. Vivek successfully drove innovation, influenced the product roadmap, and led a team of engineers based in different locations.

Their career started with research roles at The Ohio State University and Cleveland Clinic, where they served as a Graduate Research Assistant and Predoctoral Research Fellow.

Overall, Vivek Walimbe has a diverse and extensive work history in the medical industry, with a focus on research and development, engineering, and leadership.

Vivek Walimbe completed their PhD in Biomedical Engineering from The Ohio State University, which they attended from 2001 to 2006. Prior to that, they obtained their BE in Instrumentation & Control Engineering from College of Engineering Pune, where they studied from 1997 to 2001. Additionally, they pursued an Executive Education in Finance from The University of Chicago Booth School of Business, although the specific start and end years for this program are not provided.